Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis

NCT02601885 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02601885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Completed
Start date
October 18, 2016
Completion date
April 20, 2018
Enrollment
20 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis